Advanced Genomic And Cancer Diagnostics Will Expand Global Health Markets
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
07 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$39.75
25.7% undervalued intrinsic discount15 Aug
US$29.55
1Y
-8.6%7D
-1.7%1Y
-8.6%7D
-1.7%